In-House Labs Require Health Investor Due Diligence

Law360, New York (November 20, 2013, 7:21 PM EST) -- In-office laboratories are commonplace in many physician practices today. These laboratories traditionally perform screening or point of care (POC) testing. For screening tests relative to the presence of drugs, such tests are initial, qualitative drug tests conducted to identify classes of drugs present in the urine and typically are done using immunoassay. They rely on a set threshold above which a positive result is produced and therefore do not detect lower concentrations of a drug. While reimbursement for these tests varies by payor, typical reimbursement for a POC test is approximately $25.

Changes in Legislation Which Require Additional Obligations on Pain...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!